Bedaquiline in the treatment of patients with co-infection HIV/tuberculosis

Conclusions: Bedaquiline is effective and safe in patient with HIV/TB co-infection, include combination with antiretroviral therapy, even in prolonged courses (more 24 weeks).

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Galstyan, A., Borisov, S. E., Sinitsin, M. Tags: Tuberculosis Source Type: research